PARSIPPANY, N.J., Dec. 28, 2011 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, announced today that Paul Bisaro, Watson’s President and Chief Executive Officer, will provide an overview and update of the Company’s business at the 30th Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2012 at 7:30 am Pacific Standard Time (10:30 am Eastern Standard Time) at the Westin St. Francis in San Francisco, California. The presentation will be webcast live and can be accessed on Watson Pharmaceuticals’ Investor Relations Website at http://ir.watson.com. The webcast can also be accessed at the following URL:
http://jpmorgan.metameetings.com/webcasts/healthcare12/directlink?ticker=WPI
An archived version will be available by the end of the day of the live presentation and can be accessed at the same locations for 90 days.
About Watson Pharmaceuticals, Inc.
Watson Pharmaceuticals, Inc. is an integrated global specialty pharmaceutical company. The Company is engaged in the development, manufacturing, marketing and distribution of generic pharmaceuticals and specialized branded pharmaceutical products focused on Urology and Women’s Health. Watson has operations in many of the world’s established and growing international markets.
For press release and other company information, visit Watson Pharmaceuticals’ Web site at http://www.watson.com.
CONTACTS: | Investors: |
| Patty Eisenhaur |
| (862) 261-8141 |
|
|
| Media: |
| Charlie Mayr |
| (862) 261-8030 |
(Logo: http://photos.prnewswire.com/prnh/20100121/LA41294LOGO)
SOURCE Watson Pharmaceuticals, Inc.
